Comparing the cost-effectiveness of FOLFIRINOX,...

Molecular and Clinical Oncology 2017 / 05

Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer

Kurimoto, Machiko, Kimura, Michio, Usami, Eiseki, Iwai, Mina, Hirose, Tatsuya, Kawachi, Shiori, Yoshimura, Tomoaki
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Molecular and Clinical Oncology
DOI:
10.3892/mco.2017.1278
Date:
May, 2017
File:
PDF, 240 KB
english, 2017
Conversion to is in progress
Conversion to is failed